Dr. Manish Shah, MD
Claim this profileWeill Cornell Medical College
Area of expertise
Stomach Cancer
Manish Shah, MD has run 4 trials for Stomach Cancer. Some of their research focus areas include:
Esophageal Adenocarcinoma
Manish Shah, MD has run 4 trials for Esophageal Adenocarcinoma. Some of their research focus areas include:
Affiliated Hospitals
Weill Cornell Medical College
NYP/Weill Cornell Medical Center
Clinical Trials Manish Shah, MD is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting
2 awards
Phase 3
2 criteria
Targeted Therapy
for Colorectal Cancer
This research study is comparing two standard of care treatment options based on blood test results for participants who have metastatic colon cancer. The names of the potential treatments involved in this study are: * Active surveillance * FOLFIRI treatment * Nivolumab treatment * Encorafenib/Binimetinib/Cetuximab treatment * Trastuzumab + Pertuzumab
Recruiting
4 awards
Phase 3
15 criteria
More about Manish Shah, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Manish Shah, MD has experience with
- Nivolumab
- Pembrolizumab
- Telomelysin (OBP-301)
- ATP128
- BI 754091
- VSV-GP128
Breakdown of trials Manish Shah, MD has run
Stomach Cancer
Esophageal Adenocarcinoma
Esophageal Cancer
Bleeding
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Manish Shah, MD specialize in?
Manish Shah, MD focuses on Stomach Cancer and Esophageal Adenocarcinoma. In particular, much of their work with Stomach Cancer has involved dMMR positive patients, or patients who are Stage IV.
Is Manish Shah, MD currently recruiting for clinical trials?
Yes, Manish Shah, MD is currently recruiting for 5 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Manish Shah, MD has studied deeply?
Yes, Manish Shah, MD has studied treatments such as Nivolumab, Pembrolizumab, Telomelysin (OBP-301).
What is the best way to schedule an appointment with Manish Shah, MD?
Apply for one of the trials that Manish Shah, MD is conducting.
What is the office address of Manish Shah, MD?
The office of Manish Shah, MD is located at: Weill Cornell Medical College, New York, New York 10021 United States. This is the address for their practice at the Weill Cornell Medical College.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.